| 1A85 | A:85-242 | MMP8 WITH MALONIC AND ASPARAGINE BASED INHIBITOR |
| 1A86 | A:85-242 | MMP8 WITH MALONIC AND ASPARTIC ACID BASED INHIBITOR |
| 1AYK | A:1-169 | INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE, NMR, 30 STRUCTURES |
| 1B3D | B:83-255; A:83-251 | STROMELYSIN-1 |
| 1B8Y | A:83-249 | X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXED WITH NON-PEPTIDE INHIBITORS: IMPLICATIONS FOR INHIBITOR SELECTIVITY |
| 1BIW | B:83-255; A:83-251 | DESIGN AND SYNTHESIS OF CONFORMATIONALLY-CONSTRAINED MMP INHIBITORS |
| 1BKC | C:221-474; A:219-473; I:221-474; E:219-474 | CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) |
| 1BM6 | A:83-255 | SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 COMPLEXED TO A POTENT NON-PEPTIDIC INHIBITOR, NMR, 20 STRUCTURES |
| 1BQO | B:83-255; A:83-251 | DISCOVERY OF POTENT, ACHIRAL MATRIX METALLOPROTEINASE INHIBITORS |
| 1BQQ | M:114-287 | CRYSTAL STRUCTURE OF THE MT1-MMP--TIMP-2 COMPLEX |
| 1BUV | M:114-287 | CRYSTAL STRUCTURE OF THE MT1-MMP-TIMP-2 COMPLEX |
| 1BZS | A:79-243 | CRYSTAL STRUCTURE OF MMP8 COMPLEXED WITH HMR2909 |
| 1C3I | B:83-255; A:83-252 | HUMAN STROMELYSIN-1 CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812 |
| 1C8T | A:86-252; B:86-252 | HUMAN STROMELYSIN-1 (E202Q) CATALYTIC DOMAIN COMPLEXED WITH RO-26-2812 |
| 1CAQ | A:83-250 | X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY |
| 1CGE | A:102-263 | CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF |
| 1CGF | A:102-263; B:102-263 | CRYSTAL STRUCTURES OF RECOMBINANT 19-KDA HUMAN FIBROBLAST COLLAGENASE COMPLEXED TO ITSELF |
| 1CGL | A:101-268; B:106-265 | STRUCTURE OF THE CATALYTIC DOMAIN OF FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR |
| 1CIZ | A:83-250 | X-RAY STRUCTURE OF HUMAN STROMELYSIN CATALYTIC DOMAIN COMPLEXES WITH NON-PEPTIDE INHIBITORS: IMPLICATION FOR INHIBITOR SELECTIVITY |
| 1CK7 | A:46-222,A:392-449 | GELATINASE A (FULL-LENGTH) |
| 1CQR | B:83-255; A:83-251 | CRYSTAL STRUCTURE OF THE STROMELYSIN CATALYTIC DOMAIN AT 2.0 A RESOLUTION |
| 1D7X | B:583-755; A:83-251 | CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A MODIFIED PROLINE SCAFFOLD BASED INHIBITOR. |
| 1D8F | B:583-755; A:83-251 | CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A PIPERAZINE BASED INHIBITOR. |
| 1D8M | B:583-755; A:83-251 | CRYSTAL STRUCTURE OF MMP3 COMPLEXED WITH A HETEROCYCLE-BASED INHIBITOR |
| 1DMT | A:54-103,A:431-482,A:530-749 | STRUCTURE OF HUMAN NEUTRAL ENDOPEPTIDASE COMPLEXED WITH PHOSPHORAMIDON |
| 1EAK | A:108-218,A:392-452; B:108-218,B:392-450; D:108-218,D:392-450; C:108-218,C:392-449 | CATALYTIC DOMAIN OF PROMMP-2 E404Q MUTANT |
| 1EUB | A:104-274 | SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED TO A POTENT NON-PEPTIDIC SULFONAMIDE INHIBITOR |
| 1FLS | A:7-164 | SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR |
| 1FM1 | A:7-164 | SOLUTION STRUCTURE OF THE CATALYTIC FRAGMENT OF HUMAN COLLAGENASE-3 (MMP-13) COMPLEXED WITH A HYDROXAMIC ACID INHIBITOR |
| 1G05 | A:83-251; B:583-755 | HETEROCYCLE-BASED MMP INHIBITOR WITH P2'SUBSTITUENTS |
| 1G49 | B:583-755; A:83-251 | A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3 |
| 1G4K | A:83-250; B:83-250; C:83-250 | X-RAY STRUCTURE OF A NOVEL MATRIX METALLOPROTEINASE INHIBITOR COMPLEXED TO STROMELYSIN |
| 1GKC | A:110-443; B:113-443 | MMP9-INHIBITOR COMPLEX |
| 1GKD | A:110-443; B:114-443 | MMP9 ACTIVE SITE MUTANT-INHIBITOR COMPLEX |
| 1GXD | A:17-193,A:363-420; B:17-193,B:363-420 | PROMMP-2/TIMP-2 COMPLEX |
| 1HFC | A:107-263 | 1.56 ANGSTROM STRUCTURE OF MATURE TRUNCATED HUMAN FIBROBLAST COLLAGENASE |
| 1HFS | A:88-247 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-764,004 |
| 1HOV | A:1-163 | SOLUTION STRUCTURE OF A CATALYTIC DOMAIN OF MMP-2 COMPLEXED WITH SC-74020 |
| 1HY7 | B:583-755; A:83-250 | A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3 |
| 1I73 | A:80-242 | COMPLEX OF PRO-LEU-L-TRP PHOSPHONATE WITH THE CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM) |
| 1I76 | A:80-242 | COMPLEX OF 2-(BIPHENYL-4-SULFONYL)-1,2,3,4-TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID (D-TIC DERIVATIVE) WITH T CATALITIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM) |
| 1JAN | A:79-242 | COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (PHE79 FORM) |
| 1JAO | A:85-242 | COMPLEX OF 3-MERCAPTO-2-BENZYLPROPANOYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM) |
| 1JAP | A:86-242 | COMPLEX OF PRO-LEU-GLY-HYDROXYLAMINE WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM) |
| 1JAQ | A:85-242 | COMPLEX OF 1-HYDROXYLAMINE-2-ISOBUTYLMALONYL-ALA-GLY-NH2 WITH THE CATALYTIC DOMAIN OF MATRIX METALLO PROTEINASE-8 (MET80 FORM) |
| 1JH1 | A:85-242 | CRYSTAL STRUCTURE OF MMP-8 COMPLEXED WITH A 6H-1,3,4-THIADIAZINE DERIVED INHIBITOR |
| 1JIZ | A:-1-165; B:-1-165 | CRYSTAL STRUCTURE ANALYSIS OF HUMAN MACROPHAGE ELASTASE MMP-12 |
| 1JJ9 | A:85-242 | CRYSTAL STRUCTURE OF MMP8-BARBITURATE COMPLEX REVEALS MECHANISM FOR COLLAGEN SUBSTRATE RECOGNITION |
| 1JK3 | A:106-263 | CRYSTAL STRUCTURE OF HUMAN MMP-12 (MACROPHAGE ELASTASE) AT TRUE ATOMIC RESOLUTION |
| 1KBC | A:79-242; B:79-242 | PROCARBOXYPEPTIDASE TERNARY COMPLEX |
| 1L6J | A:105-215,A:390-444 | CRYSTAL STRUCTURE OF HUMAN MATRIX METALLOPROTEINASE MMP9 (GELATINASE B). |
| 1MMB | A:85-242 | COMPLEX OF BB94 WITH THE CATALYTIC DOMAIN OF MATRIX METALLOPROTEINASE-8 |
| 1MMP | A:100-264; B:100-264 | MATRILYSIN COMPLEXED WITH CARBOXYLATE INHIBITOR |
| 1MMQ | A:100-264 | MATRILYSIN COMPLEXED WITH HYDROXAMATE INHIBITOR |
| 1MMR | A:100-265 | MATRILYSIN COMPLEXED WITH SULFODIIMINE INHIBITOR |
| 1MNC | A:106-263 | STRUCTURE OF HUMAN NEUTROPHIL COLLAGENASE REVEALS LARGE S1' SPECIFICITY POCKET |
| 1OO9 | A:83-250 | ORIENTATION IN SOLUTION OF MMP-3 CATALYTIC DOMAIN AND N-TIMP-1 FROM RESIDUAL DIPOLAR COUPLINGS |
| 1OS2 | A:104-268; B:104-268; C:104-268; D:104-268; E:104-268; F:104-268 | TERNARY ENZYME-PRODUCT-INHIBITOR COMPLEXES OF HUMAN MMP12 |
| 1OS9 | A:104-268; C:104-268; D:104-268; E:104-268; F:104-268; B:104-268 | BINARY ENZYME-PRODUCT COMPLEXES OF HUMAN MMP12 |
| 1Q3A | B:104-263; A:105-263; C:106-263 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 10 |
| 1QIA | A:89-250; B:89-250; C:89-250; D:89-250 | CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN |
| 1QIB | A:88-250 | CRYSTAL STRUCTURE OF GELATINASE A CATALYTIC DOMAIN |
| 1QIC | A:89-249; B:89-249; C:89-249; D:89-249 | CRYSTAL STRUCTURE OF STROMELYSIN CATALYTIC DOMAIN |
| 1R1H | A:54-103,A:431-482,A:530-749 | STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS |
| 1R1I | A:54-103,A:431-482,A:530-749 | STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS |
| 1R1J | A:54-103,A:431-482,A:530-749 | STRUCTURAL ANALYSIS OF NEPRILYSIN WITH VARIOUS SPECIFIC AND POTENT INHIBITORS |
| 1R54 | A:204-409 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM33 |
| 1R55 | A:208-410 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN ADAM 33 |
| 1RM8 | A:124-292 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-16/MT3-MMP: CHARACTERIZATION OF MT-MMP SPECIFIC FEATURES |
| 1RMZ | | [entry was replaced by entry 5LAB without any CATH domain information] |
| 1ROS | A:106-264; B:106-264 | CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4-(4-ETHOXY[1,1-BIPHENYL]-4-YL)-4-OXOBUTANOIC ACID |
| 1S4B | P:361-511 | CRYSTAL STRUCTURE OF HUMAN THIMET OLIGOPEPTIDASE. |
| 1SLM | A:16-250 | CRYSTAL STRUCTURE OF FIBROBLAST STROMELYSIN-1: THE C-TRUNCATED HUMAN PROENZYME |
| 1SLN | A:83-250 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE N-CARBOXY-ALKYL INHIBITOR L-702,842 |
| 1SU3 | A:32-269; B:31-269 | X-RAY STRUCTURE OF HUMAN PROMMP-1: NEW INSIGHTS INTO COLLAGENASE ACTION |
| 1UEA | A:83-250; C:83-250 | MMP-3/TIMP-1 COMPLEX |
| 1UMS | A:83-248 | STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR ENSEMBLE OF 20 STRUCTURES |
| 1UMT | A:83-248 | STROMELYSIN-1 CATALYTIC DOMAIN WITH HYDROPHOBIC INHIBITOR BOUND, PH 7.0, 32OC, 20 MM CACL2, 15% ACETONITRILE; NMR AVERAGE OF 20 STRUCTURES MINIMIZED WITH RESTRAINTS |
| 1USN | A:83-247 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-142372 |
| 1UTT | A:106-264 | CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO 2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)ETHYL-4-(4-ETHOXY[1,1-BIPHENYL]-4-YL)-4-OXOBUTANOIC ACID |
| 1UTZ | A:106-264; B:106-264 | CRYSTAL STRUCTURE OF MMP-12 COMPLEXED TO (2R)-3-({[4-[(PYRI DIN-4-YL)PHENYL]-THIEN-2-YL}CARBOXAMIDO)(PHENYL)PROPANOIC ACID |
| 1XUC | A:104-272; B:104-269 | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR |
| 1XUD | A:104-272; B:104-269 | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR |
| 1XUR | A:104-272; B:104-269 | MATRIX METALLOPROTEINASE-13 COMPLEXED WITH NON-ZINC BINDING INHIBITOR |
| 1Y8J | A:54-103,A:431-482,A:530-749 | CRYSTAL STRUCTURE OF HUMAN NEP COMPLEXED WITH AN IMIDAZO[4,5-C]PYRIDINE INHIBITOR |
| 1Y93 | A:106-263 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 COMPLEXED WITH ACETOHYDROXAMIC ACID AT ATOMIC RESOLUTION |
| 1YCM | A:105-263 | SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 12 (MMP12) IN THE PRESENCE OF N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH) |
| 1YOU | A:104-271; B:104-268 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH A POTENT PYRIMIDINETRIONE INHIBITOR |
| 1Z3J | A:105-263 | SOLUTION STRUCTURE OF MMP12 IN THE PRESENCE OF N-ISOBUTYL-N-4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH) |
| 1ZP5 | A:80-242 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A N-HYDROXYUREA INHIBITOR |
| 1ZS0 | A:80-242 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A PHOSPHONATE INHIBITOR (S-ENANTIOMER) |
| 1ZTQ | A:79-243; B:79-243; D:79-243; C:79-243 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-033 |
| 1ZVX | A:80-242 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN MMP-8 AND A PHOSPHONATE INHIBITOR (R-ENANTIOMER) |
| 1ZXC | B:218-475; A:217-475 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) WITH INHIBITOR |
| 2A8H | B:218-474; A:217-475 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THIOMORPHOLINE SULFONAMIDE HYDROXAMATE INHIBITOR |
| 2AYK | A:7-163 | INHIBITOR-FREE CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE, NMR, MINIMIZED AVERAGE STRUCTURE |
| 2CLT | A:81-254; B:81-254 | CRYSTAL STRUCTURE OF THE ACTIVE FORM (FULL-LENGTH) OF HUMAN FIBROBLAST COLLAGENASE. |
| 2D1N | A:104-269; B:104-269 | COLLAGENASE-3 (MMP-13) COMPLEXED TO A HYDROXAMIC ACID INHIBITOR |
| 2D1O | A:83-253; B:83-250 | STROMELYSIN-1 (MMP-3) COMPLEXED TO A HYDROXAMIC ACID INHIBITOR |
| 2DDF | A:218-474; B:220-473 | CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH TAPI-2 |
| 2DDY | A:1-173 | SOLUTION STRUCTURE OF MATRILYSIN (MMP-7) COMPLEXED TO CONSTRAINT CONFORMATIONAL SULFONAMIDE INHIBITOR |
| 2E2D | A:104-268 | FLEXIBILITY AND VARIABILITY OF TIMP BINDING: X-RAY STRUCTURE OF THE COMPLEX BETWEEN COLLAGENASE-3/MMP-13 AND TIMP-2 |
| 2FV5 | B:220-475; A:216-476 | CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH IK682 |
| 2FV9 | A:218-475; B:220-473 | CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH JMV 390-1 |
| 2HU6 | A:106-263 | CRYSTAL STRUCTURE OF HUMAN MMP-12 IN COMPLEX WITH ACETOHYDROXAMIC ACID AND A BICYCLIC INHIBITOR |
| 2I47 | B:221-474; C:221-474; A:220-474; D:220-474 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH INHIBITOR |
| 2J0T | B:105-266; A:105-265; C:105-263 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-1 IN COMPLEX WITH THE INHIBITORY DOMAIN OF TIMP-1 |
| 2JNP | A:88-248 | SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH) |
| 2JSD | A:113-272 | SOLUTION STRUCTURE OF MMP20 COMPLEXED WITH NNGH |
| 2JT5 | A:88-248 | SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF N-HYDROXY-2-[N-(2-HYDROXYETHYL)BIPHENYL-4-SULFONAMIDE] HYDROXAMIC ACID (MLC88) |
| 2JT6 | A:88-248 | SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF 3-4'-CYANOBYPHENYL-4-YLOXY)-N-HDYDROXYPROPIONAMIDE (MMP-3 INHIBITOR VII) |
| 2K2G | A:99-263 | SOLUTION STRUCTURE OF THE WILD-TYPE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 12 (MMP-12) IN COMPLEX WITH A TIGHT-BINDING INHIBITOR |
| 2O36 | A:361-511 | CRYSTAL STRUCTURE OF ENGINEERED THIMET OLIGOPEPTIDASE WITH NEUROLYSIN SPECIFICITY IN NEUROTENSIN CLEAVAGE SITE |
| 2OI0 | A:216-481 | CRYSTAL STRUCTURE ANALYSIS 0F THE TNF-A COVERTING ENZYME (TACE) IN COMPLEXED WITH ARYL-SULFONAMIDE |
| 2OVX | A:110-443; B:110-443 | MMP-9 ACTIVE SITE MUTANT WITH BARBITURATE INHIBITOR |
| 2OVZ | A:110-443; B:114-443 | MMP-9 ACTIVE SITE MUTANT WITH PHOSPHINATE INHIBITOR |
| 2OW0 | A:110-443; B:114-443 | MMP-9 ACTIVE SITE MUTANT WITH IODINE-LABELED CARBOXYLATE INHIBITOR |
| 2OW1 | A:110-443; B:114-443 | MMP-9 ACTIVE SITE MUTANT WITH TRIFLUOROMETHYL HYDROXAMATE INHIBITOR |
| 2OW2 | A:113-443; B:114-443 | MMP-9 ACTIVE SITE MUTANT WITH DIFLUORO BUTANOIC ACID INHIBITOR |
| 2OW9 | A:83-249; B:83-248 | CRYSTAL STRUCTURE ANALYSIS OF THE MMP13 CATALYTIC DOMAIN IN COMPLEX WITH SPECIFIC INHIBITOR |
| 2OXU | A:106-263 | UNINHIBITED FORM OF HUMAN MMP-12 |
| 2OXW | A:106-263 | HUMAN MMP-12 COMPLEXED WITH THE PEPTIDE IAG |
| 2OXZ | A:106-263 | HUMAN MMP-12 IN COMPLEX WITH TWO PEPTIDES PQG AND IAG |
| 2OY2 | A:86-242; F:86-242 | HUMAN MMP-8 IN COMPLEX WITH PEPTIDE IAG |
| 2OY4 | A:86-242; F:86-242 | UNINHIBITED HUMAN MMP-8 |
| 2OZR | A:83-249; B:83-249; C:83-249; F:83-249; D:84-249; G:83-248; E:83-249; H:83-248 | MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID |
| 2PJT | B:79-243; A:79-243; D:79-243; C:79-243 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-344 |
| 2POJ | A:100-263 | NMR SOLUTION STRUCTURE OF THE INHIBITOR-FREE STATE OF MACROPHAGE METALLOELASTASE (MMP-12) |
| 2QPJ | A:54-103,A:431-482,A:530-749 | HUMAN NEP COMPLEXED WITH A BIFUNCTIONAL NEP/DPP IV INHIBITOR |
| 2SRT | A:83-255 | CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 AT PH 5.5 AND 40OC COMPLEXED WITH INHIBITOR |
| 2TCL | A:2-164 | STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR |
| 2USN | A:83-247 | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-141803 |
| 2Z2D | A:106-263 | SOLUTION STRUCTURE OF HUMAN MACROPHAGE ELASTASE (MMP-12) CATALYTIC DOMAIN COMPLEXED WITH A GAMMA-KETO BUTANOIC ACID INHIBITOR |
| 3AYK | A:7-163 | CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, MINIMIZED AVERAGE STRUCTURE |
| 3B92 | A:216-474 | NOVEL THIO-BASED TACE INHIBITORS PART 2: RATIONAL DESIGN, SYNTHESIS AND SAR OF THIOL-CONTANING ARYL SUFONES |
| 3CKI | A:219-474 | CRYSTAL STRUCTURE OF THE TACE-N-TIMP-3 COMPLEX |
| 3DWB | A:101-146,A:456-507,A:554-770 | STRUCTURE OF HUMAN ECE-1 COMPLEXED WITH PHOSPHORAMIDON |
| 3E8R | A:218-474; B:220-473 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDROXAMATE INHIBITOR |
| 3EDG | A:1-200 | CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN 1 PROTEASE DOMAIN |
| 3EDH | A:1-200 | CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN 1 PROTEASE DOMAIN IN COMPLEX WITH PARTIALLY BOUND DMSO |
| 3EDI | A:1-200 | CRYSTAL STRUCTURE OF TOLLOID-LIKE PROTEASE 1 (TLL-1) PROTEASE DOMAIN |
| 3EDZ | B:220-473; A:218-475 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDROXAMATE INHIBITOR |
| 3EWJ | A:218-475; B:220-474 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH CARBOXYLATE INHIBITOR |
| 3G42 | A:221-474; B:221-474; C:219-474; D:220-473 | CRYSTAL STRUCTURE OF TACE WITH TRYPTOPHAN SULFONAMIDE DERIVATIVE INHIBITOR |
| 3KMC | B:220-473; A:218-474 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH TARTRATE-BASED INHIBITOR |
| 3KME | A:218-474; B:220-473 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH PHENYL-PYRROLIDINYL-TARTRATE INHIBITOR |
| 3L0T | A:218-474; B:220-473 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDANTOIN INHIBITOR |
| 3L0V | B:220-473; A:216-474 | CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THE FIRST HYDANTOIN INHIBITOR OCCUPYING THE S1' POCKET |
| 3USN | A:1-168 | STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THE THIADIAZOLE INHIBITOR IPNU-107859, NMR, 1 STRUCTURE |
| 456C | A:110-269; B:111-269 | CRYSTAL STRUCTURE OF COLLAGENASE-3 (MMP-13) COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID |
| 4AYK | A:1-169 | CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, 30 STRUCTURES |
| 830C | B:104-269; A:104-271 | COLLAGENASE-3 (MMP-13) COMPLEXED TO A SULPHONE-BASED HYDROXAMIC ACID |
| 966C | A:108-264 | CRYSTAL STRUCTURE OF FIBROBLAST COLLAGENASE-1 COMPLEXED TO A DIPHENYL-ETHER SULPHONE BASED HYDROXAMIC ACID |
)
)